Stacey Dacosta Byfield PhD, MPH

Dr. Stacey DaCosta Byfield specializes in oncology health outcomes and health economics with a particular interest in retrospective claims-based research. As Therapeutic Lead for oncology studies, Dr. DaCosta Byfield provides oversight of opportunities and studies in these areas. Prior to joining Optum, she worked in the Department of Drug Use Policy and Pharmacoeconomics at the University of Texas M.D. Anderson Cancer Center as a Pharmacoeconomics Research Specialist. In this capacity, her main responsibilities included developing research designs to evaluate clinical, economic and humanistic outcomes of pharmaceutical products and services. She holds a PhD in Tumor Biology from Georgetown University and completed a basic science fellowship at the National Cancer Institute where her work focused on identifying targets of pharmaceutical intervention in breast cancer